BioGaia AB
Swedish probiotic company licensing Lactobacillus reuteri strains to other supplement manufacturers.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
BioGaia AB is a Swedish probiotic company headquartered in Stockholm, Sweden. BioGaia specializes in Lactobacillus reuteri probiotic strains backed by over 270 clinical studies involving more than 23,000 subjects. Key strains include Protectis (DSM 17938, gut health), Prodentis (oral health), and Gastrus (gastric health). BioGaia operates a wholly owned US subsidiary, BioGaia USA, in St. Louis, Missouri (full ownership effective April 2026 after acquiring the remaining 20% of distributor Nutraceutics). BioGaia operates both as a consumer product company and as a B2B ingredient supplier licensing strains to other supplement manufacturers.
Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
Capabilities
- PRODUCT TYPES
- L. reuteri Protectis (DSM 17938, Gut Health) · L. reuteri Prodentis (Oral Health) · L. reuteri Gastrus (Gastric Health) · Probiotic Strain Licensing (B2B)
- CAPABILITIES
- Clinical research or study support · Probiotics or postbiotics · North American distribution or office · Also makes finished supplements
Sources
- BioGaia Group — Clinical Studies(2026-04-02)
- BioGaia Acquires Full Ownership of US Distributor Nutraceutics(2026-04-02)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Dual business model. BioGaia sells finished consumer products AND licenses strains B2B; not a pure ingredient supplier
- Manufacturing facilities located in Sweden
- Certification details beyond cGMP not independently verified from public databases
- EU regulatory framework differs from US 21 CFR Part 111
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between BioGaia AB and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Interested in BioGaia AB?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.